The endocrine system is one of the major communication apparatus covering the whole body. It mediates not only between neighboring cells or organs, but also on distant organs through specific molecules containing an amino-acid sequence.
In carcinogenesis, it is now well accepted that normal cells can be transformed by a given mutagen and these cells may go on to proliferate if it is promoted by any given substances to which the cell has a receptor. Among the factors influencing the development of cancers, the sex hormone is one of importance. Many of the predominant cancers such as those of lung, stomach, esophagus, and liver occur preferentially in the male. However, endocrine-related tumors occurring in the pituitary and thyroid glands mainly occur in the female. Blood-borne tumors such as lymphoma and leukemia are also predominant in the female, and spontaneous or radiation induced tumors in rodents are similar to those of human tumors.
Estrogen plays a role in inducing endocrine tumors by itself without any mutagenic potency. Its effect may be through the estrogen receptor (ER) within the cellular cytoplasm as well as the nuclear acceptor. It enhances thyroid tumorigenesis by way of acting on malignant progression in the methylnitrosourea-induced rat thyroid tumors. In the pituitary gland, it is a potent tumorinogen by itself and the growth and passage of pituitary tumors both
in vivo and
in vivo have required the existence of estrogen. By the cloning of an estrogen induced pituitary tumor in a female F344 rat, we established an estrogen dependent clone, MtT/Se. Its growth
in vivo essentially necessitates estrogen, and shows dosedependent growth from 10
-12 to 10
-9 of estrogen. It has estrogen receptors and produces growth hormone. Its growth seems to be self-regulated by an insulin-like growth factor-1 (IGF-1).
View full abstract